Stock Events

Stock Events

Citius Pharmaceuticals 

$0.5427
228
+$0.00+0%Thursday 04:14

Statistics

Day High
0.5427
Day Low
0.4601
52W High
0.7603
52W Low
0.46
Volume
201
Avg. Volume
-
Mkt Cap
14.9M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Dec 17Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.95
-0.49
-0.03
0.43
Expected EPS
-0.41
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-37.43MNet Income

Analyst Ratings

$4.00Average Price Target
The highest estimate is ⁦4.00⁩.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CTXR.BOATS. It's not an investment recommendation.
Apple
29
AAPL
NVIDIA
24
NVDA
Microsoft
21
MSFT
Tesla
20
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company that competes with Citius Pharmaceuticals in the development and marketing of medical treatments, including those in areas where Citius is active.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its pharmaceutical segment, competes across various therapeutic areas, potentially overlapping with Citius Pharmaceuticals' product pipeline.
Merck
MRK
Mkt Cap368.89B
Merck & Co. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals in areas that may compete with Citius Pharmaceuticals' interests.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie operates in the pharmaceutical industry, focusing on immunology, oncology, and other areas that could directly compete with Citius Pharmaceuticals' projects.
AMGEN
AMGN
Mkt Cap251.94B
Amgen focuses on human therapeutics, including treatments in areas that might overlap with Citius Pharmaceuticals' research and development efforts.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is a biopharmaceutical company that develops and markets drugs in areas potentially competitive with Citius Pharmaceuticals' portfolio.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a global biopharmaceutical company with a broad range of products that could compete with Citius Pharmaceuticals in several therapeutic areas.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company that operates in segments that could directly compete with Citius Pharmaceuticals, especially in drug development and innovation.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of products that could compete with Citius Pharmaceuticals in various therapeutic areas.
Sanofi
SNY
Mkt Cap106.24B
Sanofi is a global healthcare leader that develops and markets drugs in several fields, including those where Citius Pharmaceuticals is seeking to make advancements.

About

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
Show More
CEO
ISIN
US17322U3068

Listings

MU
DE
47N.MU
STU
DE
47N0.STU
MU
DE
47N0.MU
BOATS
BOATS
CTXR.BOATS

0 Comments

Share your thoughts

FAQs

What is Citius Pharmaceuticals stock price today?▼
The current price of CTXR.BOATS is $0.54 USD — it has increased by +0% in the past 24 hours. Watch Citius Pharmaceuticals stock price performance more closely on the chart.
What is Citius Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Citius Pharmaceuticals stocks are traded under the ticker CTXR.BOATS.
What is Citius Pharmaceuticals market cap?▼
Today Citius Pharmaceuticals has the market capitalization of 14.9M
When is the next Citius Pharmaceuticals earnings date?▼
Citius Pharmaceuticals is going to release the next earnings report on December 17, 2026.
What were Citius Pharmaceuticals earnings last quarter?▼
CTXR.BOATS earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.36 USD resulting in a +5.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Citius Pharmaceuticals revenue for the last year?▼
Citius Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Citius Pharmaceuticals net income for the last year?▼
CTXR.BOATS net income for the last year is -37.43M USD.
In which sector is Citius Pharmaceuticals located?▼
Citius Pharmaceuticals operates in the Other sector.
When did Citius Pharmaceuticals complete a stock split?▼
The last stock split for Citius Pharmaceuticals was on November 26, 2024 with a ratio of 1:25.